KoppleJ.D.Abnormal amino acid and protein metabolism in uremia.Kidney Int1978; 14: 340–8.
6.
LindholmN., AlvestrandA., FurstP., BergströmJ.Plasma and muscle free amino acids during continuous ambulatory peritoneal dialysis.Kidney Int1989; 35: 1219–26.
7.
Divino–FilhoJ.C., BárányP., StehleP., FurstP., BergströmJ.Free amino-acid levels simultaneously collected in plasma, muscle, and erythrocytes of uremic patients.Nephrol Dial Transplant1997; 12(11): 2339–48.
8.
JonesM.R., KoppleJ.D.Valine metabolism in normal and chronically uremic man.Am J Clin Nutr1978; 31: 1660–4.
9.
GaribottoG., PaolettiE., FioriniF., RussoR., RobaudoC., DeferrariG.Peripheral metabolism of branched-chain keto acids in patients with chronic renal failure.Miner Electrolyte Metab1993; 19: 25–31.
10.
SulimanM.E., AnderstamB., BergströmJ.Evidence of taurine depletion and accumulation of cysteinesulfinic acid in chronic dialysis patients.Kidney Int1996; 50: 1713–17.
11.
MoustaphaA., GuptaA., RobinsonK., ArheartK., JacobsenD.W., SchreiberM.J.Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis.Kidney Int1999; 55: 1470–5.
12.
Van der NiepenP., AlleinS., VerbeelenD.Muscle metabolism in uremia and the effects of amino acid supplementation.Nephron1998; 79: 387–98.
13.
WolfsonM., LaidlawS.A., Flugel–LinkR.M., StrongC.J., SaluskyI.B., KoppleJ.D.Effect of vitamin B-6 deficiency on plasma amino acid levels in chronically azotemic rats.J Nutr1986; 116(10): 1865–72.
14.
GjessingJ.Addition of amino acids to peritoneal dialysis fluid.Lancet1968; ii: 812.
15.
Van BiesenW., FaictD., BoerW., LameireN.Further animal and human experience with a 0.6% amino acid/ 1.4% glycerol peritoneal dialysis solution.Perit Dial Int1997; 17(Suppl 2): S56–61.
16.
OreopoulosD.G., CrasswellerP., KatirtzoglouA., OgilvieR., ZellermanG., RodellaH.Amino acids as an osmotic agent (instead of glucose) in continuous ambulatory peritoneal dialysis. In: LegrainM., ed. Proceedings of the 1st International Symposium on CAPD; 1979; Paris, France. Amsterdam: Excerpta Medica; 1979: 335–40.
17.
WilliamsP.F., MarlissE.B., AndersonG.H., OrenA., SteinA.N., KhannaR.Amino acid absorption following intraperitoneal administration in CAPD patients.Perit Dial Bull1982; 2: 124–30.
18.
KhannaR., WuG., RodellaH., OreopoulosD.G.Use of amino acid containing solution in CAPD patients.Perit Dial Bull1984; 4(Suppl 3): S121–4.
19.
OrenA., WyG., AndersonG.H., MarlissE., KhannaR., PettitJ.Effective use of amino acid dialysate over four weeks in CAPD patients.Perit Dial Bull1983; 3: 66–73.
20.
PedersenF.B., DragsholtC., LaierE., FrifeltJ.J., TrostmannA.F., EkelundS.A.Alternate use of amino acid and glucose solutions in CAPD.Perit Dial Bull1985; 5: 215–18.
21.
SchillingH., WuG., PettitJ., MitwalliA., AndersonH.G., OgilvieR.Use of amino acid containing solutions in CAPD patients after peritonitis: Results of a prospective controlled trial.Proc EDTA–ERA1985; 22: 421–5.
22.
DombrosN.V., PrutisK., TongM., AndersonG.H., HarrisonJ., SombolosK.Six-month overnight intraperitoneal amino-acid infusion in CAPD. No effect on nutritional status.Perit Dial Int1990; 10: 79–84.
23.
YoungG.A., DibbleJ.B., HobsonS.M., TompkinsL., GibsonJ., TurneyJ.H.The use of an amino-acid-based CAPD fluid over 12 weeks.Nephrol Dial Transplant1989; 4: 285–92.
24.
BrunoM., BagnisC., MarangellaM., RoveraL., CantaluppiA., LinariF.CAPD with an amino acid dialysis solution: A long-term, cross-over study.Kidney Int1989; 35: 1189–94.
25.
ScanzianiR., DozioB., IacuittiG.CAPD in diabetics: Use of amino acids. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin, 1990; 6: 53–5.
26.
ArfeenS., GoodshipT.H., KirkwoodA., WardM.K.The nutritional/metabolic and hormonal effects of 8 weeks of continuous ambulatory peritoneal dialysis with a 1% amino acid solution.Clin Nephrol1990; 33: 192–9.
27.
KoppleJ.D., BernardD., MessanaJ., SwartzR., BergströmJ., LindholmB.Treatment of malnourished CAPD patients with an amino acid based dialysate.Kidney Int1995; 47: 1148–57.
28.
FallerB., AparicioM., FaictD., De VosC., de PrecigoutV., LarroumetN.Clinical evaluation of an optimized 1.1% amino-acid solution for peritoneal dialysis.Nephrol Dial Transplant1995; 10: 1432–7.
29.
ChertowG.M., LazarusJ.M., LydenM.E., CaudryD., NordbergP., LowrieE.G.Laboratory surrogates of nutritional status after administration of intraperitoneal amino acid-based solutions in ambulatory peritoneal dialysis patients.J Renal Nutr1995; 5: 116–23.
30.
MisraM., AshworthJ., ReaveleyD.A., MullerB., BrownE.A.Nutritional effects of amino acid dialysate (Nutrineal) in CAPD patients. In: KhannaR., ed. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications, 1996; 12: 311–4.
31.
JonesM., HagenT., BoyleC.A., VoneshE., HamburgerR., CharytanC.Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: Results of a multicenter outpatient study.Am J Kidney Dis1998; 32: 761–9.
32.
MaurerO., SaxenhoferH., JaegerP.H., CasezJ.P., DescoeudresC., HorberF.F.Six-month overnight administration of intraperitoneal amino acids does not improve lean mass.Clin Nephrol1996; 45: 303–9.
33.
GrzegorzewskaA., MariakI., Dobrowolska–ZachwiejaA., SzajdakL.Effects of amino acid dialysis solution on the nutrition of continuous ambulatory peritoneal dialysis patients.Perit Dial Int1999; 19: 262–70.
34.
LimV.S., YarasheskiK.E., FlaniganM.J.The effect of uremia, acidosis, and dialysis treatment on protein metabolism: A longitudinal leucine kinetic study.Nephrol Dial Transplant1998; 13: 1723–30.
35.
BergströmJ., WangT., LindholmB.Factors contributing to catabolism in end-stage renal disease patients.Miner Electrolyte Metab1998; 24: 92–101.
36.
DelarueJ., MaingourdC., ObjoisM., PinaultM., CohenR., CouetC.Effects of an amino acid dialysate on leucine metabolism in continuous ambulatory peritoneal dialysis patients.Kidney Int1999; 56: 1934–43.
37.
BrunoM., BagnisC., CossedduD., TricerriA., RoveraL., LinariF.CAPD con aminoacidi: Due mesi a scambi alterni in 5 pazienti [Abstract].G Ital Nephrol1992; S2: 92.
38.
SteinhauerH.B., Lubrich–BirkerI., KlutheR., BaumannG., SchollmeyerP.Effects of amino acid based dialysis solution on peritoneal permeability and prostanoid generation in patients undergoing continuous ambulatory peritoneal dialysis.Am J Nephrol1992; 12: 61–7.
39.
DoumaC.E., de WaartD.R., StruijkD.G., KredietR.T.Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: A potential role for nitric oxide?Clin Nephrol1996; 45: 295–302.
40.
BrulezH.F., van GuldenerC., DonkerA.J., ter WeeP.M.The impact of an amino acid–based peritoneal dialysis fluid on plasma total homocysteine levels, lipid profile and body fat mass.Nephrol Dial Transplant1999; 14(1): 154–9.
41.
JonesM., KalilR., BlakeP., MartisL., OreopoulosD.G.Modification of an amino-acid solution for peritoneal dialysis to reduce risk of acidemia.Perit Dial Int1997; 17: 66–71.
42.
FerianiM., DissegnaD., LaGrecaG., Passlick–DeetjenJ.Short-term clinical study with bicarbonate-containing peritoneal dialysis solution.Perit Dial Int1993; 13: 296–301.
